FDA Inspection
Onyx Pharmaceuticals, Inc., a Subsidiary of Amgen, Inc.FDA Inspection 765467 - Onyx Pharmaceuticals, Inc., a Subsidiary of Amgen, Inc. - January 20, 2012
Discuss this record with AI
Record Details
This FDA Inspection record concerns Onyx Pharmaceuticals, Inc., a Subsidiary of Amgen, Inc., with an inspection on January 20, 2012, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- January 20, 2012
- Product Type
- Drugs
Open in Dashboard
ID · 1a73ad03-4282-4023-aab8-00cb7d7d3c5b
Violation Codes1
21 CFR 312.50
Full citation text and observation details available on the Dashboard.